These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7513078)

  • 1. Serum levels of oncofetal markers CA 125, CA 19-9, and alpha-fetoprotein in children with hereditary tyrosinemia type I.
    Pitkänen S; Salo MK; Kuusela P; Holmberg C; Simell O; Heikinheimo M
    Pediatr Res; 1994 Feb; 35(2):205-8. PubMed ID: 7513078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alpha1-fetoprotein: physiology, pathology and diagnosis especially in childhood (author's transl)].
    Knöpfle G; Becker M; Rotthauwe HW
    Klin Padiatr; 1977 Jul; 189(4):207-26. PubMed ID: 70546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
    Baumann U; Duhme V; Auth MK; McKiernan PJ; Holme E
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):77-82. PubMed ID: 16819381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Tao LY; Cai L; He XD; Liu W; Qu Q
    Am Surg; 2010 Nov; 76(11):1210-3. PubMed ID: 21140686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Timor J; Thambyrajah V
    Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
    Hostetter MK; Levy HL; Winter HS; Knight GJ; Haddow JE
    N Engl J Med; 1983 May; 308(21):1265-7. PubMed ID: 6188953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
    Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
    Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma in tyrosinemia type 1 without clear increase of AFP.
    van Ginkel WG; Gouw AS; van der Jagt EJ; de Jong KP; Verkade HJ; van Spronsen FJ
    Pediatrics; 2015 Mar; 135(3):e749-52. PubMed ID: 25667247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum type III procollagen in children with type I hereditary tyrosinemia.
    Pitkänen S; Salo MK; Vettenranta K; Näntö-Salonen K; Heikinheimo M
    J Pediatr Gastroenterol Nutr; 1999 Jul; 29(1):38-41. PubMed ID: 10400101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
    Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N
    Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of combined assays of serum ferritin, alpha-1-antitrypsin and alpha-fetoprotein in liver cancer.
    Tang DJ; Lang YM; Feng YZ
    Chin Med J (Engl); 1992 Nov; 105(11):900-4. PubMed ID: 1284788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prognostic value of focusylated alpha-fetoprotein measurement in liver cancer patients after surgery].
    Yin ZF; Wu MC; Yu ZQ
    Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):654-6. PubMed ID: 7539735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ferritin in hepatocellular carcinoma.
    Zhou XD; Stahlhut MW; Hann HL; London WT
    Hepatogastroenterology; 1988 Feb; 35(1):1-4. PubMed ID: 2452122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical excision of a hepatoma complicating chronic tyrosinemia (author's transl)].
    Costil J; Taïeb B; Buffe D; Garel L; Boccon-Gibod L; Gruner M; Brissaud HE
    Arch Fr Pediatr; 1980 Mar; 37(3):187-90. PubMed ID: 6258535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
    Yap SF; Peh SC
    Malays J Pathol; 1991 Dec; 13(2):115-8. PubMed ID: 1726642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.
    Hu KQ; Kyulo NL; Lim N; Elhazin B; Hillebrand DJ; Bock T
    Am J Gastroenterol; 2004 May; 99(5):860-5. PubMed ID: 15128351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.